Literature DB >> 1643161

TNF induces cytoplasmic vesicles in actinomycin D-treated K 562 cells.

R Munker1, L Greither, M Darsow, S Pander, W Wilmanns.   

Abstract

We report here that tumor necrosis factor alpha (TNF) induces peculiar cytoplasmic vesicles in the human erythromyeloid leukemia cell line K 562, sensitized to the cytotoxic action of TNF by a treatment with the inhibitor of transcription actinomycin D. These vesicles are well delineated ultrastructurally. The formation of these vesicles is characteristic for the combination of actinomycin D with TNF and precedes the changes of apoptosis and cellular disintegration. These vesicles correspond to an intermediate step in the cytotoxicity caused by TNF and may indicate that reactive metabolites are involved in the mechanism of action of TNF.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1643161     DOI: 10.1007/bf01715127

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  6 in total

1.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.

Authors:  C B Lozzio; B B Lozzio
Journal:  Blood       Date:  1975-03       Impact factor: 22.113

Review 2.  Tumour necrosis factor.

Authors:  M K Brenner
Journal:  Br J Haematol       Date:  1988-06       Impact factor: 6.998

3.  [Myeloblastic leukemia. Cytochemistry, electron microscopy and cytogenetics].

Authors:  D Huhn; F Schmalzl; U Krug
Journal:  Blut       Date:  1971-10

Review 4.  Tumor necrosis factor: an update on basic research and clinical applications.

Authors:  M Schleuning; R Munker
Journal:  Klin Wochenschr       Date:  1990-09-03

Review 5.  Cytotoxic mechanism of tumor necrosis factor-alpha.

Authors:  J W Larrick; S C Wright
Journal:  FASEB J       Date:  1990-11       Impact factor: 5.191

6.  In vitro action of tumor necrosis factor on myeloid leukemia cells.

Authors:  R Munker; P Koeffler
Journal:  Blood       Date:  1987-04       Impact factor: 22.113

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.